Immunotherapy Biomarkers and Patient Selection

preview_player
Показать описание
Dr. Julie Brahmer, Johns Hopkins University, discusses the use of biomarker testing and mutational burden to select patients for specific immunotherapies in lung cancer, renal cell carcinoma and melanoma.

Рекомендации по теме
join shbcf.ru